Teach-Back Discharge Education to Improve Self-Care and Reduce 30-Day Readmissions in Heart Failure Patients

NCT ID: NCT07280208

Last Updated: 2025-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

57 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-11

Study Completion Date

2025-11-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to improve how patients with heart failure understand and manage their condition after leaving the hospital. Many heart failure patients are readmitted within 30 days due to confusion about their discharge instructions and difficulty following self-care routines. The study will test whether a structured discharge education session using the "teach-back" method-where patients repeat instructions in their own words-can help improve their knowledge and self-care behaviors. The goal is to reduce hospital readmissions and help patients feel more confident managing their heart failure at home.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Heart failure is a chronic and progressive condition affecting millions of adults in the United States. Despite advances in treatment, nearly one in four patients are readmitted to the hospital within 30 days of discharge, often due to poor understanding of discharge instructions and inadequate self-care. These readmissions contribute to worse health outcomes and increased healthcare costs.

This study evaluates the effectiveness of a structured discharge education intervention using the teach-back method. The teach-back method is a communication technique in which patients are asked to repeat discharge instructions in their own words. This approach helps confirm understanding, reinforce learning, and promote active engagement in self-care.

The study uses a quasi-experimental, pre-test/post-test design to assess changes in patients' knowledge and self-care behaviors before and after the intervention. Participants are adults hospitalized with systolic heart failure (LVEF ≤ 40%) who meet specific clinical criteria. Each participant receives a 30-minute individualized education session at discharge, covering key self-care topics such as medication adherence, symptom monitoring, fluid restriction, and dietary modifications. Printed educational materials from the American Heart Association are also provided.

To measure outcomes, participants complete the European Heart Failure Self-care Behavior Scale (EHFScB-9) before and after the intervention. Thirty-day readmission data are collected through a retrospective review of hospital records. The study aims to determine whether teach-back education improves self-care behaviors and reduces 30-day readmission rates.

This project has been reviewed and exempted by the Nova Southeastern University Institutional Review Board under Exempt Category 2. It aligns with national goals to improve patient education, reduce preventable readmissions, and enhance the quality of care for individuals with heart failure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Heart Failure Hospitalization Readmission, Hospital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All participants receive the same intervention: structured discharge education using the teach-back method.

There is no control group or comparison between multiple interventions. The study uses a pre-test/post-test design within a single group to evaluate changes in self-care behaviors and readmission rates.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Teach-Back Education Intervention

Participants in this arm will receive a structured discharge education session using the teach-back method. The session will be delivered in person at hospital discharge and will cover key heart failure self-care behaviors, including medication adherence, symptom monitoring, fluid restriction, and dietary modifications. Participants will be asked to restate instructions in their own words to confirm understanding. Printed educational materials from the American Heart Association will also be provided.

Group Type EXPERIMENTAL

Teach-Back Discharge Education

Intervention Type BEHAVIORAL

A structured, 30-minute discharge education session delivered in person using the teach-back method. Participants are asked to restate instructions in their own words to confirm understanding. The session covers key heart failure self-care behaviors including medication adherence, symptom monitoring, fluid restriction, and dietary modifications. Printed educational materials from the American Heart Association are also provided.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Teach-Back Discharge Education

A structured, 30-minute discharge education session delivered in person using the teach-back method. Participants are asked to restate instructions in their own words to confirm understanding. The session covers key heart failure self-care behaviors including medication adherence, symptom monitoring, fluid restriction, and dietary modifications. Printed educational materials from the American Heart Association are also provided.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18 years and older
* Diagnosed with systolic heart failure with a left ventricular ejection fraction (LVEF) ≤ 40%
* Classified as New York Heart Association (NYHA) Class II, III, or IV
* Categorized as American College of Cardiology/American Heart Association (ACC/AHA) Stage C or D
* Currently hospitalized at the project site
* Able to read and understand English at an 8th grade reading level
* Have access to a smartphone or tablet capable of scanning QR codes and connecting to the internet
* Provide voluntary informed consent via the REDCap platform

Exclusion Criteria

* Cognitive impairment
* Non-English speaking
* Unwilling to participate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nova Southeastern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sara Bierschenk

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Virginia Waters, Ph.D., MSN, MBA, RN, CNE-BC

Role: STUDY_CHAIR

Nova Southeastern University, Ron and Kathy Assaf College of Nursing

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

HCA Florida JFK Hospital

Atlantis, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-398

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Heart Failure Medication Adherence
NCT03402750 COMPLETED NA